The Vanguard Group 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 1:34 pm Unchanged |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
The Vanguard Group | 18,118,494 7.770% |
0 (Unchanged) |
Filing |
2024-11-04 11:00 am Purchase |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
The Vanguard Group | 18,118,494 7.770% |
5,226,619![]() (+40.54%) |
Filing |
2024-02-13 4:56 pm Purchase |
2023-12-29 | 13G | ADMA Biologics, Inc. ADMA |
The Vanguard Group | 12,891,875 5.710% |
12,891,875![]() (New Position) |
Filing |